Currently, there are 37.05M common shares owned by the public and among those 24.62M shares have been available to trade.
Insiders at the company have transacted a total of 4 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 4 of these insider trades were purchases, accounting for 109,250 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The company’s stock has a 5-day price change of -7.89% and -33.76% over the past three months. CYN shares are trading 36.42% year to date (YTD), with the 12-month market performance down to -82.49% lower. It has a 12-month low price of $0.12 and touched a high of $1.38 over the same period. CYN has an average intraday trading volume of 11.09 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 16.14%, 6.79%, and -64.46% respectively.
Institutional ownership of Cyngn Inc (NASDAQ: CYN) shares accounts for 22.38% of the company’s 37.05M shares outstanding.
It has a market capitalization of $7.65M and a beta (3y monthly) value of -2.00. The earnings-per-share (ttm) stands at -$0.60. Price movements for the stock have been influenced by the stock’s volatility, which stands at 27.91% over the week and 21.89% over the month.
Analysts forecast that Cyngn Inc (CYN) will achieve an EPS of $Cyngn Inc. for the current quarter, $0.20 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $Cybin Inc. while analysts give the company a high EPS estimate of $Community Health Systems, Inc.. Comparatively, EPS for the current quarter was $Dyne Therapeutics, Inc. a year ago. Earnings per share for the fiscal year are expected to increase by 4.19%, and 48.15% over the next financial year.
Looking at the support for the CYN, a number of firms have released research notes about the stock. Aegis Capital stated their Buy rating for the stock in a research note on November 16, 2021, with the firm’s price target at $13.
